EN
HI
Summary
As of 10 Nov, 2026, Tavexia Lifecare stock price is ₹1.16. During the trading session, the stock has moved between an intraday low of ₹1.16 and an intraday high of ₹1.19. Over the last 52 weeks, Tavexia Lifecare has traded between ₹0.49 and ₹1.25.
The stock has recorded a trading volume of 3,11,296 shares,. Its Average Traded Price (ATP) is ₹1.16, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 6800 @ ₹1.16.
Tavexia Lifecare has an upper circuit limit of ₹1.21 and a lower circuit limit of ₹1.11. The total value traded stands at ₹3.61 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Tavexia Lifecare also offers a dividend yield of 0%.
Tavexia Lifecare Share Price Chart
Tavexia Lifecare Share Key Metrics
Volume
3.11 L
Market Cap
44.50 CR
LTQ@LTP
6800@1.16
ATP
1.16
Var Margin
100 %
Circuit Range
1.11-1.21
Delivery %
100 %
Value
3.61 L
ASM/GSM
No
Market Lot
1
Tavexia Lifecare Fundamentals
P/E Ratio
0
P/B Ratio
1.05
Div. Yield
0
Sector P/E
61.48
Sector P/B
1.74
Sec. Div. Yield
73.7
Tavexia Lifecare Resistance and Support
Pivot 1.17
Resistance
First Resistance
1.18
Second Resistance
1.2
Third Resistance
1.21
Support
First Support
1.15
Second Support
1.14
Third Support
1.12
Tavexia Lifecare Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 1.19 | 1.15 | -0.86% | 1.19 | 1.15 |
| Sun Nov 08 2026 | 1.14 | 1.16 | 0.87% | 1.19 | 1.14 |
| Fri Nov 06 2026 | 1.15 | 1.15 | -0.86% | 1.16 | 1.15 |
Tavexia Lifecare Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-07 | Others |
| 2026-09-04 | A.G.M. |
| 2026-08-04 | Quarterly Results |
| 2026-06-30 | Others |
| 2026-06-04 | Audited Results |
| 2026-05-30 | Audited Results |
| 2026-02-19 | Quarterly Results |
| 2026-02-16 | Quarterly Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-25 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-03 | Others |
| 2025-08-12 | Quarterly Results |
| 2025-06-21 | Others |
| 2025-05-05 | Audited Results & Rights issue |
| 2025-04-30 | Audited Results & Rights issue |
| 2025-04-23 | Others |
| 2025-02-11 | Quarterly Results |
| 2025-01-25 | Others |
| 2025-01-18 | Allotment of Bonus shares |
| 2024-12-02 | Bonus issue |
| 2024-11-12 | Quarterly Results |
| 2024-08-30 | Stock Split & A.G.M. |
| 2024-08-16 | Rights issue |
| 2024-08-05 | Quarterly Results |
| 2023-10-11 | Others |
Tavexia Lifecare News
Tavexia Lifecare Ltd - 539519 - Announcement
Sattva Sukun Lifecare's board approved a proposal to raise up to Rs.68 crores via preferential issue, rights issue, or other modes. The capital will be used to finance the proposed acquisition of a 60% stake in Meyonex Pharmaceuticals, with final terms to be decided subsequently.
Nov 04 2026 21:41:05
Tavexia Lifecare Ltd - 539519 - Board Meeting Outcome for Outcome Of Board Meeting
Tavexia Lifecare reported Q2 FY27 cons. revenue of ₹5.04 crores and a net loss of ₹0.40 crores. The board granted in-principle approval to raise up to ₹68 crores to finance the 60% acquisition of Meyonex Pharmaceuticals. The company also changed its RTA to Skyline Financial Services.
Nov 04 2026 21:28:45
Read More
Tavexia Lifecare Management
| Name | Position |
|---|---|
| Poonam Rani | Company Secretary & Compliance Officer |
| Mit Tarunkumar Brahmbhatt | Managing Director |
Tavexia Lifecare FAQs
The Buying Price of Tavexia Lifecare share is 1.16 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Tavexia Lifecare stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Tavexia Lifecare, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Tavexia Lifecare shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Tavexia Lifecare shares is 1.05. Useful to assess the stock's value relative to its book value.
To assess Tavexia Lifecare’s valuation compare Sector P/E, P/B which are 61.48 & 1.74 with sector averages, along with growth rates and financial metrics.
The Market Cap of Tavexia Lifecare is 44.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Tavexia Lifecare share price is 1.25 & 0.49. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Tavexia Lifecare belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in TAVEXIA
